Ouster Q2: Revenue +30%, gross margin 45%, $229M cash runway; losses narrow amid litigation

Snapshot - Ouster, Inc. (NYSE: OUST)

What's happening inside the company
* Revenue momentum: Q2 2025 revenue $35,049,000, up 30% year-over-year; six‑month revenue $67,681,000, up 28% YoY.
* Improved gross margin: Q2 gross profit $15,842,000; gross margin 45% (vs. 34% in Q2 2024).
* Losses narrowing: Q2 net loss $(20,612,000) vs. $(23,869,000) a year earlier; six‑month net loss $(42,629,000) vs. $(47,718,000) last year.
* Strong liquidity position: cash and cash equivalents $76,120,000; short‑term investments $150,385,000; total cash/short‑term/restricted ≈ $229.1 million as reported.
* Capital raise executed: sold 3,522,177 shares under ATM in Q2 2025 for gross proceeds ≈ $60.0M (net ≈ $58.5-58.8M); remaining ATM capacity ≈ $40M as of 6/30/2025.
* Balance sheet growth: total assets $321,840,000; total liabilities $100,807,000; stockholders' equity $221,033,000 (6/30/2025).
* Shares outstanding: 57,800,303 reported at 6/30/2025; 57,819,244 reported as outstanding on 8/8/2025.

Key income‑statement items & metrics (facts)
* Revenue - Q2 2025: $35,049,000 (Q2 2024: $26,990,000).
* Cost of revenue - Q2 2025: $19,207,000 (up 7% YoY).
* Gross profit - Q2 2025: $15,842,000; Gross margin 45% (Q2 2024: 34%).
* R&D - Q2 2025: $17,147,000 (up 19% YoY); six months: $32,132,000 (up 14% YoY).
* Sales & marketing - Q2 2025: $6,978,000 (flat YoY); six months: $13,401,000.
* General & administrative - Q2 2025: $18,539,000 (up 41% YoY); six months: $34,444,000 (up 34% YoY).
* Stock‑based compensation - Q2 2025: $13,226,000; six months: $21,724,000.
* Net loss per share - Q2 2025: $(0.38) (basic & diluted); weighted‑average shares Q2 2025: 54,466,143.
* Interest income helped: other income, net (Q2) $2,594,000 (mostly interest on investments).

Positives to highlight
* Revenue growth and accelerating Americas & Asia sales - supports scale-up thesis.
* Gross margin expansion to 45% in Q2 driven by lower inventory charges and ERC benefits - indicates improving unit economics.
* Strong cash + short‑term investments (~$229M) and active ATM program give runway flexibility - operating cash burn improved (operating cash use for six months: $(6,188,000) vs. $(27,366,000) prior year).
* No outstanding debt as of 6/30/2025 (repaid UBS facility in 2024) - reduces interest burden and financial leverage risk.
* R&D investment sustained (critical for product roadmap: REV7, DF sensors, new chips) - supports long‑term technology leadership.

Negatives / risks exposed by the income statement and notes
* Continued operating losses: loss from operations Q2 2025 $(26,822,000); company still unprofitable and cumulative deficit $955,700,000.
* Rising G&A and litigation costs: G&A up 41% in Q2 driven largely by litigation and settlement activity; the company accrued $11.7M related to Velodyne legacy and Ouster legal proceedings as of 6/30/2025.
* Heavy stock‑based comp expense: $21.7M for six months, dilutive to GAAP results and a recurring non‑cash cost.
* Revenue concentration & customer supply risk: several customers and two suppliers represent material portions of revenue/purchases (Customer A/E/D/F/G and Supplier A/B disclosures).
* Trade/tariff uncertainty: new tariffs announced in Q2 2025 on imports (including from Thailand) could raise product costs; company notes potential impact despite contractual customer pass‑through in some cases.
* Material weaknesses in internal controls: disclosure controls not effective as of 6/30/2025 - remediation ongoing but this increases execution and reporting risk.

Operational and cash flow highlights
* Operating cash flow improved: six months ended 6/30/2025 used $(6,188,000) vs. $(27,366,000) in prior year period (non‑cash charges, reduced working capital drag aided improvement).
* Investing: net cash used in investing $(23,877,000) in six months (net purchases/sales of short‑term investments).
* Financing: net cash provided $60,173,000 driven primarily by ATM proceeds.
* Inventory down to $13,903,000 (6/30/2025) from $16,417,000 (12/31/2024) - inventory trend improving.

Capital structure & contingent items
* Amazon warrant: 3,270,987 shares issuable under Amazon warrant as of 6/30/2025 (2,330,704 vested); strike adjusted to $50.59 after antidilution.
* Potential dilution: ~13.3M potentially dilutive securities excluded from EPS (options, warrants, RSUs, ESPP, RSAs) at 6/30/2025.
* ATM availability: sold ~3.52M shares in Q2; ~ $40M capacity remaining under new ATM (as of 6/30/2025).
* Legal contingencies and settlements remain notable drivers of G&A and accrued liabilities; several legacy Velodyne matters have been settled or reserved with insurance offsets, but litigation exposure continues (including PTAB/IPR proceedings and arbitration with Hesai).

Bottom line - clear progress on revenue and margins, solid cash runway from investments and ATM activity, but Ouster remains unprofitable with noteworthy litigation, rising G&A, high stock‑based compensation and trade/supplier concentration risks. Management is investing in R&D to secure product leadership while working to remediate internal control weaknesses.